China NMPA Drug Inspection - Bozhou Baisheng Pharmaceutical Co., Ltd. - Astragalus membranaceus (processed)
China NMPA drug inspection for Bozhou Baisheng Pharmaceutical Co., Ltd. published March 20, 2018. Drug: Astragalus membranaceus (processed). The "Jiangsu Province 2018 First Issue Drug Quality Bulletin," published on March 20, 2018, by the Jiangsu Provincial Fo
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Bozhou Baisheng Pharmaceutical Co., Ltd. published March 20, 2018. Drug: Astragalus membranaceus (processed). The "Jiangsu Province 2018 First Issue Drug Quality Bulletin," published on March 20, 2018, by the Jiangsu Provincial Fo
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox